Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has provided an announcement.
NeuroScientific Biopharmaceuticals Ltd has announced the formation of a Clinical & Scientific Advisory Board to guide its scientific innovation and product development. The board, led by Chief Medical Officer Dr. Catherine Cole, includes experts in nephrology, gastroenterology, and respiratory medicine. This strategic move aims to enhance the company’s clinical strategy and address unmet medical needs in immune-mediated inflammatory disorders.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Ltd is an Australian biotechnology company focused on developing novel technologies for immune-mediated inflammatory diseases.
Average Trading Volume: 348,444
Technical Sentiment Signal: Buy
Current Market Cap: A$46.56M
See more insights into NSB stock on TipRanks’ Stock Analysis page.